LICENSE AGREEMENTLicense Agreement • July 29th, 2021 • Cyclerion Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 29th, 2021 Company Industry JurisdictionThis License Agreement (this “Agreement”) is made effective as of June 3, 2021 (the “Effective Date”) by and between Cyclerion Therapeutics, Inc., a Massachusetts corporation (“Cyclerion”) and Akebia Therapeutics, Inc., a Delaware corporation (“Akebia”) (each of Cyclerion and Akebia being a “Party”, and collectively, the “Parties”).